Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
644
archived clinical trials in
Dental

Botox for Treatment of TMJ Disorder With Bruxism
Phase 1 Study of Role of Botox in Myofascial Temporomandibular Disorder
Status: Enrolling
Updated:  1/21/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Botox for Treatment of TMJ Disorder With Bruxism
Phase 1 Study of Role of Botox in Myofascial Temporomandibular Disorder
Status: Enrolling
Updated: 1/21/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
MOTOR: Maternal Oral Therapy to Reduce Obstetric Risk
MOTOR: Maternal Oral Therapy to Reduce Obstetric Risk
Status: Enrolling
Updated:  1/25/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
MOTOR: Maternal Oral Therapy to Reduce Obstetric Risk
MOTOR: Maternal Oral Therapy to Reduce Obstetric Risk
Status: Enrolling
Updated: 1/25/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer
Preliminary Clinical Trial Investigating the Ability of Plant Exosomes to Abrogate Oral Mucositis Induced by Combined Chemotherapy and Radiation in Head and Neck Cancer Patients
Status: Enrolling
Updated:  1/28/2018
James Graham Brown Cancer Center
mi
from
Louisville, KY
Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer
Preliminary Clinical Trial Investigating the Ability of Plant Exosomes to Abrogate Oral Mucositis Induced by Combined Chemotherapy and Radiation in Head and Neck Cancer Patients
Status: Enrolling
Updated: 1/28/2018
James Graham Brown Cancer Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Evaluation of a "Flash-free" Adhesive Resin for Orthodontic Bracket Bonding
Use of a "Flash-free" Adhesive Resin for Orthodontic Bracket Bonding: a Clinical Study of Bonding Time, Bond Survival, and Adhesive Remnant Cleanup
Status: Enrolling
Updated:  1/29/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Evaluation of a "Flash-free" Adhesive Resin for Orthodontic Bracket Bonding
Use of a "Flash-free" Adhesive Resin for Orthodontic Bracket Bonding: a Clinical Study of Bonding Time, Bond Survival, and Adhesive Remnant Cleanup
Status: Enrolling
Updated: 1/29/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain
A Phase 3, Double-blind, Randomized Safety And Efficacy Study Comparing Multiple Administrations Of Ibu 250 Mg/Apap 500 Mg (Administered As Two Tablets Of Ibu/Apap 125 Mg/250 Mg) To Placebo In The Treatment Of Post Surgical Dental Pain In Adult Subjects
Status: Enrolling
Updated:  1/31/2018
Pharmaceutical Research Associates Inc.
mi
from
Salt Lake City, UT
A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain
A Phase 3, Double-blind, Randomized Safety And Efficacy Study Comparing Multiple Administrations Of Ibu 250 Mg/Apap 500 Mg (Administered As Two Tablets Of Ibu/Apap 125 Mg/250 Mg) To Placebo In The Treatment Of Post Surgical Dental Pain In Adult Subjects
Status: Enrolling
Updated: 1/31/2018
Pharmaceutical Research Associates Inc.
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Biomarkers of Periodontal Disease Progression
Biomarkers of Periodontal Disease Progression
Status: Enrolling
Updated:  2/6/2018
NYU College of Dentistry
mi
from
New York, NY
Biomarkers of Periodontal Disease Progression
Biomarkers of Periodontal Disease Progression
Status: Enrolling
Updated: 2/6/2018
NYU College of Dentistry
mi
from
New York, NY
Click here to add this to my saved trials
Biomarkers of Periodontal Disease Progression
Biomarkers of Periodontal Disease Progression
Status: Enrolling
Updated:  2/6/2018
Southern Illinois University
mi
from
Edwardsville, IL
Biomarkers of Periodontal Disease Progression
Biomarkers of Periodontal Disease Progression
Status: Enrolling
Updated: 2/6/2018
Southern Illinois University
mi
from
Edwardsville, IL
Click here to add this to my saved trials
Biomarkers of Periodontal Disease Progression
Biomarkers of Periodontal Disease Progression
Status: Enrolling
Updated:  2/6/2018
State University of New York at Buffalo
mi
from
Buffalo, NY
Biomarkers of Periodontal Disease Progression
Biomarkers of Periodontal Disease Progression
Status: Enrolling
Updated: 2/6/2018
State University of New York at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Biomarkers of Periodontal Disease Progression
Biomarkers of Periodontal Disease Progression
Status: Enrolling
Updated:  2/6/2018
The Forsyth Institute
mi
from
Cambridge, MA
Biomarkers of Periodontal Disease Progression
Biomarkers of Periodontal Disease Progression
Status: Enrolling
Updated: 2/6/2018
The Forsyth Institute
mi
from
Cambridge, MA
Click here to add this to my saved trials
Biomarkers of Periodontal Disease Progression
Biomarkers of Periodontal Disease Progression
Status: Enrolling
Updated:  2/6/2018
University of Michigan School of Dentistry
mi
from
Ann Arbor, MI
Biomarkers of Periodontal Disease Progression
Biomarkers of Periodontal Disease Progression
Status: Enrolling
Updated: 2/6/2018
University of Michigan School of Dentistry
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Tooth Smart Healthy Start: Oral Health Advocates in Public Housing
Oral Health Advocates in Public Housing
Status: Enrolling
Updated:  2/11/2018
Boston University
mi
from
Boston, MA
Tooth Smart Healthy Start: Oral Health Advocates in Public Housing
Oral Health Advocates in Public Housing
Status: Enrolling
Updated: 2/11/2018
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated:  2/12/2018
University of Alabama at Birmingham Department of Ostetrics and Gynecology
mi
from
Birmingham, AL
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated: 2/12/2018
University of Alabama at Birmingham Department of Ostetrics and Gynecology
mi
from
Birmingham, AL
Click here to add this to my saved trials
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated:  2/12/2018
Department of Periodontology, UNC School of Dentistry
mi
from
Chapel Hill, NC
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated: 2/12/2018
Department of Periodontology, UNC School of Dentistry
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated:  2/12/2018
Duke University
mi
from
Durham, NC
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated: 2/12/2018
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated:  2/12/2018
University of Texas Health Science Center
mi
from
San Antonio, TX
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Maternal Oral Therapy to Reduce Obstetric Risk Kids
Status: Enrolling
Updated: 2/12/2018
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Comparison of Three Toothpastes for the Prevention and Reduction of White Spot Lesions
Comparison of Clinpro™ 5000 1.1% Sodium Fluoride Anti-Cavity Toothpaste, Clinpro™ Tooth Crème, and MI-Paste Plus for the Prevention and Reduction of White Spot Lesions in Orthodontic Treatment
Status: Enrolling
Updated:  2/14/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Comparison of Three Toothpastes for the Prevention and Reduction of White Spot Lesions
Comparison of Clinpro™ 5000 1.1% Sodium Fluoride Anti-Cavity Toothpaste, Clinpro™ Tooth Crème, and MI-Paste Plus for the Prevention and Reduction of White Spot Lesions in Orthodontic Treatment
Status: Enrolling
Updated: 2/14/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study Evaluating Ibuprofen 600 mg Extended Release (ER) For Dental Pain
Ibuprofen 600 Mg Extended Release (er) Single-dose Dental Pain Study
Status: Enrolling
Updated:  2/22/2018
Jean Brown Research Center
mi
from
Salt Lake City, UT
Study Evaluating Ibuprofen 600 mg Extended Release (ER) For Dental Pain
Ibuprofen 600 Mg Extended Release (er) Single-dose Dental Pain Study
Status: Enrolling
Updated: 2/22/2018
Jean Brown Research Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Status: Enrolling
Updated:  2/23/2018
University of Rochester
mi
from
Rochester, NY
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Status: Enrolling
Updated: 2/23/2018
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Status: Enrolling
Updated:  3/12/2018
UF Health Cancer Center
mi
from
Gainesville, FL
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Status: Enrolling
Updated: 3/12/2018
UF Health Cancer Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Status: Enrolling
Updated:  3/12/2018
University of Miami-Sylvester CCC Clinical Research Services
mi
from
Miami, FL
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Status: Enrolling
Updated: 3/12/2018
University of Miami-Sylvester CCC Clinical Research Services
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Status: Enrolling
Updated:  3/12/2018
Soroka Medical Center
mi
from
Beer Sheba,
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Status: Enrolling
Updated: 3/12/2018
Soroka Medical Center
mi
from
Beer Sheba,
Click here to add this to my saved trials
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Status: Enrolling
Updated:  3/12/2018
Mount Sinai Beth Israel Phillips Ambulatory Care Center
mi
from
New York, NY
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Status: Enrolling
Updated: 3/12/2018
Mount Sinai Beth Israel Phillips Ambulatory Care Center
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Status: Enrolling
Updated:  3/12/2018
NYU Clinical Cancer Center
mi
from
New York, NY
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Phase 2 Study to Evaluate the Safety and Efficacy of IZN-6N4 for the Prevention of Chemo-Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer
Status: Enrolling
Updated: 3/12/2018
NYU Clinical Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies
Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies
Status: Enrolling
Updated:  3/14/2018
University of South Florida, Health Informatics Institute
mi
from
Tampa, FL
Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies
Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies
Status: Enrolling
Updated: 3/14/2018
University of South Florida, Health Informatics Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
TEACH: Technology Evaluation to Address Child Health
TEACH: Technology Evaluation to Address Child Health
Status: Enrolling
Updated:  3/20/2018
Massachusetts General Hospital
mi
from
Boston, MA
TEACH: Technology Evaluation to Address Child Health
TEACH: Technology Evaluation to Address Child Health
Status: Enrolling
Updated: 3/20/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of Zimmer Puros® Allograft vs. Creos™ Allograft for Alveolar Ridge Preservation
Clinical and Histological Evaluation of Zimmer Puros® Allograft vs. Creos™ (Low-cost) Allograft for Alveolar Ridge Preservation Following Exodontia
Status: Enrolling
Updated:  3/30/2018
University of Florida College of Dentistry-Periodontics
mi
from
Gainesville, FL
Evaluation of Zimmer Puros® Allograft vs. Creos™ Allograft for Alveolar Ridge Preservation
Clinical and Histological Evaluation of Zimmer Puros® Allograft vs. Creos™ (Low-cost) Allograft for Alveolar Ridge Preservation Following Exodontia
Status: Enrolling
Updated: 3/30/2018
University of Florida College of Dentistry-Periodontics
mi
from
Gainesville, FL
Click here to add this to my saved trials
Oral Gut Liver Axis in Cirrhosis
Oral Gut Liver Axis in Cirrhosis
Status: Enrolling
Updated:  4/2/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Oral Gut Liver Axis in Cirrhosis
Oral Gut Liver Axis in Cirrhosis
Status: Enrolling
Updated: 4/2/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Incentives for Daily Tooth Brushing to Reduce Gingivitis
Status: Enrolling
Updated:  4/4/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Incentives for Daily Tooth Brushing to Reduce Gingivitis
Status: Enrolling
Updated: 4/4/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
Morton Plant Mease Health Care
mi
from
Clearwater, FL
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
Morton Plant Mease Health Care
mi
from
Clearwater, FL
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
Karmanos Cancer Center
mi
from
Detroit, MI
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
Karmanos Cancer Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
Temple University Hospital
mi
from
Philadelphia, PA
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
Cancer Specialists of Southern Texas
mi
from
Corpus Christi, TX
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
Cancer Specialists of Southern Texas
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
VA Puget Sound Health Care Syatem
mi
from
Seattle, WA
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
VA Puget Sound Health Care Syatem
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
Detroit Clinical Research Center PC
mi
from
Farmington Hills, MI
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
Detroit Clinical Research Center PC
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
Mount Sinai School of Medicine
mi
from
New York, NY
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
SUNY Upstate Medical University
mi
from
Syracuse, NY
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated:  4/20/2018
St Vincent's Hospital
mi
from
Darlinghurst,
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Status: Enrolling
Updated: 4/20/2018
St Vincent's Hospital
mi
from
Darlinghurst,
Click here to add this to my saved trials
Percocet vs. Bupivicaine for Toothaches in the ED
A Comparison of the Analgesic Efficacy of Oral Opioid Medication vs. Injected Local Anesthetic in Emergency Department Patients With Toothache
Status: Enrolling
Updated:  4/23/2018
Stony Brook University Hospital
mi
from
Stony Brook, NY
Percocet vs. Bupivicaine for Toothaches in the ED
A Comparison of the Analgesic Efficacy of Oral Opioid Medication vs. Injected Local Anesthetic in Emergency Department Patients With Toothache
Status: Enrolling
Updated: 4/23/2018
Stony Brook University Hospital
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Randomized, Double-Blind, Single-Dose, Efficacy and Safety Study of Test Acetaminophen Tablet in Postoperative Dental Pain
A Randomized, Double-Blind, Placebo- and Active- Controlled, Single-Dose, Efficacy and Safety Study of a Test Acetaminophen 500 mg Tablet in Postoperative Dental Pain
Status: Enrolling
Updated:  4/24/2018
Jean Brown Research
mi
from
Salt Lake City, UT
Randomized, Double-Blind, Single-Dose, Efficacy and Safety Study of Test Acetaminophen Tablet in Postoperative Dental Pain
A Randomized, Double-Blind, Placebo- and Active- Controlled, Single-Dose, Efficacy and Safety Study of a Test Acetaminophen 500 mg Tablet in Postoperative Dental Pain
Status: Enrolling
Updated: 4/24/2018
Jean Brown Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials